logo

For the Inventor, By the Inventor

Cheshire, CT, United States of America

Shirong Zhu

This inventor holds 9 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Lion Bioscience Ag, Viiv Healthcare UK (No.5) Limited. Active years: 2003-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirong Zhu. Retrieved from https://idiyas.com/inventor/shirong-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Cheshire, CT (US) (2003 - 2013)
  • Wallingford, CT (US) (2018)

Company Filing History:

goldMedal7 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 17 
 
Lion Bioscience Ag
 patents
bronzeMedal1 out of 45 
 
Viiv Healthcare UK (No.5) Limited
 patents

Years Active: 2003-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 9855230 - Inhibitors of human immunodeficiency virus replication (2018-01-02),
2. 8362004 - Piperazine analogs as broad-spectrum influenza antivirals (2013-01-29),
3. 7732434 - Macrocyclic acyl guanidines as beta-secretase inhibitors (2010-06-08),
4. 7678784 - Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors (2010-03-16),
5. 7612069 - Acyl guanidines as beta-secretase inhibitors (2009-11-03),
6. 7408071 - N-aryl pyrrolidine derivatives as beta-secretase inhibitors (2008-08-05),
7. 7390925 - Oxime-containing acyl guanidines as beta-secretase inhibitors (2008-06-24),
8. 7273882 - Aminoacetamide acyl guanidines as β-secretase inhibitors (2007-09-25),
9. 6660858 - 2-aminobenzoxazole derivatives and combinatorial libraries thereof (2003-12-09),

Title: The Innovative Contributions of Shirong Zhu

Introduction

Shirong Zhu is a prominent inventor based in Cheshire, CT, USA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of nine patents to his name, Zhu's work has the potential to impact the treatment of various viral infections.

Latest Patents

Among his latest patents, Zhu has developed inhibitors of human immunodeficiency virus (HIV) replication. These compounds, including pharmaceutically acceptable salts, offer new methods for treating HIV infection. Additionally, he has created piperazine analogs as broad-spectrum influenza antivirals. This compound is designed to prevent and treat influenza virus infections, showcasing his innovative approach to combating viral diseases.

Career Highlights

Zhu has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antiviral therapies.

Collaborations

Throughout his career, Zhu has collaborated with talented individuals such as Samuel Gerritz and Shuhao Shi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.

Conclusion

Shirong Zhu's contributions to antiviral research and his impressive portfolio of patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…